Effect of dietary sodium on platelet alpha 2-adrenergic receptors in essential hypertension. 1985

T Ashida, and T Tanaka, and M Yokouchi, and M Kuramochi, and F Deguchi, and G Kimura, and S Kojima, and K Ito, and M Ikeda

To study the aggregation, adhesion, and specific binding of an alpha 2-antagonist, [3H]rauwolscine, to the platelet membrane fractions, platelets were obtained from 30 patients with essential hypertension and nine normotensive subjects fed a high sodium diet (NaCl, 16-18 g/day) for 7 days and thereafter a low sodium diet (NaCl, 1-3 g/day) for 7 days. The patients with essential hypertension were classified as either salt responders (all those who had greater than 7% decrease in mean arterial pressure from the high to low sodium period) or salt nonresponders (all others). In salt responders, the number of alpha 2-adrenergic receptors on platelet membrane fraction was increased from 523.4 +/- 55.4 fmol/mg of protein in the high sodium period to 669.4 +/- 84.0 fmol/mg of protein in the low sodium period (p less than 0.01), whereas it did not change in salt nonresponders. In contrast, the epinephrine-induced platelet aggregation through alpha 2-adrenergic receptors was decreased in nonresponders, from 47.3 +/- 7.4% in the high sodium period to 24.5 +/- 9.3% in the low sodium period (p less than 0.05), while it did not change in responders. No significant change in the number of alpha 2-adrenergic receptors or epinephrine-induced platelet aggregation was observed in the normotensive subjects.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010973 Platelet Adhesiveness The process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other "foreign" surfaces. Adhesiveness, Platelet,Adhesivenesses, Platelet,Platelet Adhesivenesses
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011942 Receptors, Adrenergic, alpha One of the two major pharmacological subdivisions of adrenergic receptors that were originally defined by the relative potencies of various adrenergic compounds. The alpha receptors were initially described as excitatory receptors that post-junctionally stimulate SMOOTH MUSCLE contraction. However, further analysis has revealed a more complex picture involving several alpha receptor subtypes and their involvement in feedback regulation. Adrenergic alpha-Receptor,Adrenergic alpha-Receptors,Receptors, alpha-Adrenergic,alpha-Adrenergic Receptor,alpha-Adrenergic Receptors,Receptor, Adrenergic, alpha,Adrenergic alpha Receptor,Adrenergic alpha Receptors,Receptor, alpha-Adrenergic,Receptors, alpha Adrenergic,alpha Adrenergic Receptor,alpha Adrenergic Receptors,alpha-Receptor, Adrenergic,alpha-Receptors, Adrenergic
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Ashida, and T Tanaka, and M Yokouchi, and M Kuramochi, and F Deguchi, and G Kimura, and S Kojima, and K Ito, and M Ikeda
March 1983, Clinical science (London, England : 1979),
T Ashida, and T Tanaka, and M Yokouchi, and M Kuramochi, and F Deguchi, and G Kimura, and S Kojima, and K Ito, and M Ikeda
November 1988, Hypertension (Dallas, Tex. : 1979),
T Ashida, and T Tanaka, and M Yokouchi, and M Kuramochi, and F Deguchi, and G Kimura, and S Kojima, and K Ito, and M Ikeda
January 1986, Archives of general psychiatry,
T Ashida, and T Tanaka, and M Yokouchi, and M Kuramochi, and F Deguchi, and G Kimura, and S Kojima, and K Ito, and M Ikeda
January 1982, Clinical and experimental hypertension. Part A, Theory and practice,
T Ashida, and T Tanaka, and M Yokouchi, and M Kuramochi, and F Deguchi, and G Kimura, and S Kojima, and K Ito, and M Ikeda
September 1992, Psychiatry research,
T Ashida, and T Tanaka, and M Yokouchi, and M Kuramochi, and F Deguchi, and G Kimura, and S Kojima, and K Ito, and M Ikeda
January 1992, Comptes rendus des seances de la Societe de biologie et de ses filiales,
T Ashida, and T Tanaka, and M Yokouchi, and M Kuramochi, and F Deguchi, and G Kimura, and S Kojima, and K Ito, and M Ikeda
January 1987, Hypertension (Dallas, Tex. : 1979),
T Ashida, and T Tanaka, and M Yokouchi, and M Kuramochi, and F Deguchi, and G Kimura, and S Kojima, and K Ito, and M Ikeda
October 1992, Acta paediatrica Japonica : Overseas edition,
T Ashida, and T Tanaka, and M Yokouchi, and M Kuramochi, and F Deguchi, and G Kimura, and S Kojima, and K Ito, and M Ikeda
June 1984, Bollettino della Societa italiana di biologia sperimentale,
T Ashida, and T Tanaka, and M Yokouchi, and M Kuramochi, and F Deguchi, and G Kimura, and S Kojima, and K Ito, and M Ikeda
March 1982, Endocrinology,
Copied contents to your clipboard!